tiprankstipranks
Trending News
More News >

Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Panbela Therapeutics to $5 from $16 and keeps a Buy rating on the shares following the Q4 results. The analyst cites the 1-for-20 reverse split in January for the target drop.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1